Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism ABL inhibitors(Abl family tyrosine kinases inhibitors), Bcr-Abl inhibitors(Bcr-Abl tyrosine kinase inhibitors), CSK inhibitors(C-terminal Src kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | United States | - | |
Chronic Myelomonocytic Leukemia | Preclinical | United States | - |